Trial intelligence / Profile preview

Adsorbed Acellular DTaP Combined Vaccine in Infants and Toddlers

CTR20190621Phase 4Completed

Sponsor
Yuxi Watson Biotechnology
Start
Mar 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of diphtheria + tetanus + pertussis (acellular, component) vaccine (adsorbed) in pertussis, diphtheria, Tetanus, sponsored by Yuxi Watson Biotechnology. Started Mar 2019; status: completed.

02

Drugs

diphtheria + tetanus + pertussis (acellular, component) vaccine (adsorbed)
03

Conditions

pertussisdiphtheriaTetanus

Beyond the preview

Go deeper on CTR20190621.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20190621.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call